Micron (NASDAQ: MU) is spending billions to expand the memory infrastructure powering artificial intelligence. Its new fabs could strengthen pricing power and long-term growth, but they could also revive the oversupply …
(RTTNews) - GRAIL, Inc. (GRAL) announced that the U.S. FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet on September 23, 2026 to review the company's Premarket Approval app…
The S&P 500 Index ($SPX) (SPY) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.19%. September E-mini S&P futures (ESU26) r…
The dollar index (DXY00) dropped to a 7-week low on Friday and finished down -0.41%. The dollar tumbled on Friday after the US July payroll report showed an unexpected decline in nonfarm payrolls and a smaller-than-expe…
(RTTNews) - After fluctuating wildly earlier in the day, the price of crude oil has moved sharply higher over the course of the trading session on Friday.
The S&P 500 Index ($SPX) (SPY) today is up +0.61%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.25%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.00%. September E-mini S&P futures (ESU26) are up +0.66%, an…
The S&P 500 Index ($SPX) (SPY) closed down -0.18% on Thursday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.85%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.39%. September E-mini S&P futures (…
Falling launch costs, improving space hardware, and rising public and private investment could help the industry grow to a projected $1.8 trillion by 2035, according to McKinsey estimates.
The S&P 500 Index ($SPX) (SPY) closed down -0.18% on Thursday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.85%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.39%. September E-mini S&P futures (…
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
(RTTNews) - Replimune Group, Inc. (REPL) announced that the U.S. FDA has granted accelerated approval for TUDRIQEVTM, in combination with Nivolumab (Bristol Myers Squibb), for adults with unresectable advanced cutaneous…
In this episode of Motley Fool Rule Breaker Investing, Motley Fool co-founder David Gardner dives into the Mailbag, covering questions about investing, artificial intelligence, financial freedom, World Cup soccer, custo…